Latest News

Press Releases

2012

May 10, 2012
ThromboGenics Announces Business Update Q1 …more »

April 17, 2012
ThromboGenics Resubmits BLA for Ocriplasmin with the FDA… more »

April 13, 2012
ThromboGenics – Transparency Declaration … more »

April 3, 2012
ThromboGenics has in total 35,691,432 shares outstanding … more »

March 29, 2012
ThromboGenics Completes Private Placement Raising €77.8 million  … more »

March 16, 2012
ThromboGenics Enters into Commercialization Agreement for Ocriplasmin with Alcon outside the United States  … more

March 8, 2012
ThromboGenics Announces Business Update and 2011 Full-Year Results … more »

March 5, 2012
ThromboGenics Opens New U.S. Headquarters… more »

February 24, 2012
ThromboGenics to Present at the Citi 2012 Global Health Care Conference in New York… more »

February 2, 2012
ThromboGenics Announces that the FDA Intends to Grant Ocriplasmin Priority Review… more »

January 5, 2012
ThromboGenics Publishes Financial Calender 2012… more »